Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2004-002767-25Phase 4Completed
Phase 4, randomised, double-blind trial of calendula + echinacea in irritant contact dermatitis (7 arms), sponsored by WALA Heilmittel GmbH. Primary endpoints: Effect of herbal ointments on transepidermal water loss and Comparative efficacy on skin inflammation. Started Apr 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2004-002767-25.